Press Release|

Ulrich Faessler appointed CEO of SHL Medical

Pressrelease 201712 800x480

Ulrich Faessler has been appointed CEO of SHL Medical.

Since the founding of SHL Group (hereinafter referred to as “SHL”) in the late 1980s, SHL’s founder Roger Samuelsson has been the CEO and Group President. For SHL to advance and adapt to the demands of the growing organization, a new global CEO role for SHL’s Medical division will be created.

The new global CEO for SHL Medical Holding will be Ulrich Faessler. Ulrich has been with SHL for over seven years and has been the Asian Managing Director for SHL Medical for the past five years. Ulrich will assume the global CEO role on January 1, 2018.

Roger Samuelsson, CEO of SHL Group, commented: “I am delighted that Ulrich has agreed to take on the responsibility of leading SHL Medical Holding. Ulrich knows SHL, our customers and the industry, and I’m convinced he’s the right person to lead the company in the future.”

Roger will remain as President of SHL Group and will work closely with Ulrich.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News